JPWO2021182574A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021182574A5
JPWO2021182574A5 JP2021532007A JP2021532007A JPWO2021182574A5 JP WO2021182574 A5 JPWO2021182574 A5 JP WO2021182574A5 JP 2021532007 A JP2021532007 A JP 2021532007A JP 2021532007 A JP2021532007 A JP 2021532007A JP WO2021182574 A5 JPWO2021182574 A5 JP WO2021182574A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
chain variable
variable region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021532007A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021182574A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/009799 external-priority patent/WO2021182574A1/ja
Publication of JPWO2021182574A1 publication Critical patent/JPWO2021182574A1/ja
Publication of JPWO2021182574A5 publication Critical patent/JPWO2021182574A5/ja
Priority to JP2025156924A priority Critical patent/JP2025181951A/ja
Pending legal-status Critical Current

Links

JP2021532007A 2020-03-12 2021-03-11 Pending JPWO2021182574A1 (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025156924A JP2025181951A (ja) 2020-03-12 2025-09-22 癌の治療及び/又は予防のための医薬品

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020043022 2020-03-12
PCT/JP2021/009799 WO2021182574A1 (ja) 2020-03-12 2021-03-11 癌の治療及び/又は予防のための医薬品

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025156924A Division JP2025181951A (ja) 2020-03-12 2025-09-22 癌の治療及び/又は予防のための医薬品

Publications (2)

Publication Number Publication Date
JPWO2021182574A1 JPWO2021182574A1 (https=) 2021-09-16
JPWO2021182574A5 true JPWO2021182574A5 (https=) 2024-02-28

Family

ID=77670660

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021532007A Pending JPWO2021182574A1 (https=) 2020-03-12 2021-03-11
JP2025156924A Pending JP2025181951A (ja) 2020-03-12 2025-09-22 癌の治療及び/又は予防のための医薬品

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025156924A Pending JP2025181951A (ja) 2020-03-12 2025-09-22 癌の治療及び/又は予防のための医薬品

Country Status (7)

Country Link
US (1) US20230159635A1 (https=)
EP (1) EP4119160A4 (https=)
JP (2) JPWO2021182574A1 (https=)
KR (1) KR20220151684A (https=)
BR (1) BR112022018161A2 (https=)
CA (1) CA3175279A1 (https=)
WO (1) WO2021182574A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0911926A2 (pt) * 2008-08-05 2020-08-18 Toray Industries, Inc composições farmacêuticas, anticorpos e usos de um anticorpo ou um fragmento do mesmo.
CN118852442A (zh) * 2023-04-26 2024-10-29 上海麦科思生物医药有限公司 抗ptk7抗体及其用途

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
DE69535243T2 (de) 1994-07-13 2007-05-10 Chugai Seiyaku K.K. Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
DK1069185T3 (da) 1998-04-03 2011-06-27 Chugai Pharmaceutical Co Ltd Humaniseret antistof mod human vævsfaktor (TF) og fremgangsmåde til at konstruere humaniseret antistof
DK1071700T3 (da) 1998-04-20 2010-06-07 Glycart Biotechnology Ag Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet
US6737056B1 (en) 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
CA2704600C (en) 1999-04-09 2016-10-25 Kyowa Kirin Co., Ltd. A method for producing antibodies with increased adcc activity
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
CA2512729C (en) 2003-01-09 2014-09-16 Macrogenics, Inc. Identification and engineering of antibodies with variant fc regions and methods of using same
US8388955B2 (en) 2003-03-03 2013-03-05 Xencor, Inc. Fc variants
DE10359795A1 (de) 2003-12-19 2005-07-21 Bayer Technology Services Gmbh Strangverdampfervorrichtung
US8811201B2 (en) * 2008-04-18 2014-08-19 Telefonaktiebolaget Lm Ericsson (Publ) Access network selection in a multi-access network environment
BRPI0911926A2 (pt) * 2008-08-05 2020-08-18 Toray Industries, Inc composições farmacêuticas, anticorpos e usos de um anticorpo ou um fragmento do mesmo.
EP2711018A1 (en) 2009-06-22 2014-03-26 MedImmune, LLC Engineered Fc regions for site-specific conjugation
EP2480671B8 (en) 2009-09-22 2015-10-28 ProBioGen AG Process for producing molecules containing specialized glycan structures
DK2532680T3 (da) * 2010-02-04 2015-07-20 Toray Industries Medicinsk sammensætning til behandling og/eller forebyggelse af cancer
HUE040012T2 (hu) 2010-02-04 2019-02-28 Toray Industries Gyógyászati ágens rák kezelésére és/vagy megelõzésére
DK2532366T3 (da) 2010-02-04 2017-01-02 Toray Industries Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer
CA2788545C (en) * 2010-02-04 2019-03-26 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
RU2603742C2 (ru) 2010-02-04 2016-11-27 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и/или профилактики рака
US9115200B2 (en) 2010-02-04 2015-08-25 Toray Industries, Inc. Pharmaceutical composition for treating cancer using a monoclonal antibody having immunological reactivity with CAPRIN-1
JP2013528357A (ja) 2010-03-29 2013-07-11 ザイムワークス,インコーポレイテッド 強化又は抑制されたエフェクター機能を有する抗体
RU2595400C2 (ru) 2011-08-04 2016-08-27 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли
US9181348B2 (en) 2011-08-04 2015-11-10 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prophylaxis of cancer
EP2740794B1 (en) 2011-08-04 2018-04-04 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prophylaxis of cancer
PT2740796T (pt) 2011-08-04 2017-07-26 Toray Industries Composição farmacêutica para o tratamento e/ou profilaxia de cancro
PL2740793T3 (pl) 2011-08-04 2018-04-30 Toray Industries, Inc. Kompozycja leku do leczenia i/lub zapobiegania nowotworowi
PT2740489T (pt) 2011-08-04 2017-01-10 Toray Industries Composição farmacêutica para o tratamento e/ou a prevenção do cancro pancreático
WO2013125654A1 (ja) 2012-02-21 2013-08-29 東レ株式会社 癌の治療及び/又は予防用医薬組成物
ES2739612T3 (es) 2012-02-21 2020-02-03 Toray Industries Composición farmacéutica para el tratamiento de cáncer
US9260513B2 (en) * 2012-02-21 2016-02-16 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
BR112014021103A2 (pt) 2012-02-21 2019-10-15 Toray Industries, Inc Anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
WO2013147176A1 (ja) 2012-03-30 2013-10-03 東レ株式会社 胆嚢癌の治療及び/又は予防用医薬組成物
JP6107654B2 (ja) 2012-03-30 2017-04-05 東レ株式会社 肝臓癌の治療及び/又は予防用医薬組成物
CN112587671A (zh) 2012-07-18 2021-04-02 博笛生物科技有限公司 癌症的靶向免疫治疗
AU2014303375B2 (en) 2013-08-09 2019-07-04 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
US9177410B2 (en) * 2013-08-09 2015-11-03 Ayla Mandel System and method for creating avatars or animated sequences using human body features extracted from a still image
AU2016271138A1 (en) * 2015-05-29 2017-12-07 Merrimack Pharmaceuticals, Inc. Combination cancer therapies
AU2019242520B2 (en) * 2018-03-30 2026-02-26 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
JP2020043022A (ja) 2018-09-13 2020-03-19 オンキヨー株式会社 面状発光装置

Similar Documents

Publication Publication Date Title
AU2019242520B2 (en) Pharmaceutical composition for treatment and/or prevention of cancer
EP4582100A1 (en) Medicament for treatment and/or prevention of cancer
JPWO2021182573A5 (https=)
EP4119156A1 (en) Medicament for treatment and/or prevention of cancer
EP4360649A1 (en) Medicament for treatment and/or prevention of cancer
JPWO2021182574A5 (https=)
JPWO2021182571A5 (https=)
JPWO2021182570A5 (https=)
JP7715041B2 (ja) 癌の治療及び/又は予防のための医薬品
JP7793986B2 (ja) 癌の治療及び/又は予防のための医薬品
EP4119160A1 (en) Medicament for treatment and/or prevention of cancer
JPWO2021182572A5 (https=)
JP7793985B2 (ja) 癌の治療及び/又は予防のための医薬品
EP4360648A1 (en) Medicament for treatment and/or prevention of cancer
EP4378476A1 (en) Medicament for treatment and/or prevention of cancer
EP4578458A1 (en) Medicament for treatment and/or prevention of cancer
EP4578457A1 (en) Pharmaceutical for treating and/or preventing cancer
EP4582101A1 (en) Medicament for treatment and/or prevention of cancer
EP4640235A1 (en) Medicament for treatment and/or prevention of cancer